Publicaciones

...menos

1. Miriam Ulloa, Fernando Macías, Gonzalo Martínez de la Escalera, Edith Arnold., Acciones del peróxido de hidrógeno (H2O2) como señalizador redox y como agente de estrés oxidante en la diabetes mellitus., Tip Revista Especializada en Ciencias Quimico-Biológicas, noviembre de 2023; 26, 1-10

2. Ruggiero C, Altieri B, Arnold E, Siqueiros-Marquez L, Doghman-Bouguerra M, Detomas M, Durand N, Jarjat M, Chatonnet F, Fassnacht M, Deutschbein T, Clapp C, Lalli E. , Analysis of mouse adrenal gland links prolactin signaling and adrenal-specific super-enhancers to human endocrine disorders. , Clinical and Translational Medicine, noviembre de 2021; 11, e630

3. González-Luna, I. A., Juárez-Tapia, C., Aguilar-Vázquez, A., Arnold, E., Díaz-Cintra, S., Miranda-Anaya, M., & Díaz-Muñoz, M., Changes in 24 h Rhythmicity of Spontaneous Locomotor Activity in the Triple Transgenic Mouse for Alzheimer’s Disease (3xTg-AD) in a Jet Lag Protocol: Correlations with Retinal Sensitivity., Journal of Circadian Rhythms, enero de 2021; 19(1), 1-15

4. Aroña, R.M., Arnold, E., Macías, F., López-Casillas, F., Clapp, C., Martínez de la Escalera, G. , Vasoinhibin generation and effect on neuronal apoptosis in the hippocampus of late mouse embryos. , AMERICAN JOURNAL OF PHYSIOLOGY: Regulatory, Integrative and Comparative Physiology, abril de 2020; 318(4), R760-771

5. Arnold, E., Thebault, S., Aroña, R.M., Martínez de la Escalera, G., Clapp, C. , Prolactin mitigates deficiencies of retinal function associated with aging. , Neurobiology of Aging, enero de 2020; 85, 38-48

6. Melo, Z., Castillo, X., Moreno-Carranza, B., Ledesma-Colunga, M.G., López-Casillas, F., Ruíz-Herrera, X., Clapp, C., Martínez de la Escalera, G. , Vasoinhibin suppresses nerve growth factor-induced differentiation and survival of PC12 pheochromocytoma cells. , Neuroendocrinology, agosto de 2019; 109(2), 152-164

7. Castillo, X., Melo, Z., Varela-Echevarría, A., Tamáriz, E., Aroña, R.M., Arnold, E., Clapp, C., Martínez de la Escalera, G. , Vasoinhibins suppresses the ability of NGF and VEGF to stimulate neurite growth in rat primary sensory neurons. , Neuroendocrinology, marzo de 2018; 106(3), 221-233

8. Ruiz-Herrera X, de Los Ríos EA, Díaz JM, Lerma-Alvarado RM, de la Escalera LM, López-Barrera F, Lemini M, Arnold E, de la Escalera GM, Clapp C, Macotela Y., Prolactin Promotes Adipose Tissue Fitness and Insulin Sensitivity in Obese Males., Endocrinology, enero de 2017; 158(1), 56-68

9. Kong D, Gong L, Arnold E, Shanmugam S, Fort PE, Gardner TW, Abcouwer SF., Insulin-like growth factor 1 rescues R28 retinal neurons from apoptotic death through ERK-mediated BimEL phosphorylation independent of Akt., Experimental Eye Research, octubre de 2016; 151, 82-95

10. Meléndez García R*, Arredondo Zamarripa R*, Arnold E* (*, equal contribution), Ruiz-Herrera X, Noguez Imm R, Baeza Cruz G, Adán N, Binart N, Riesgo-Escovar N, Goffin V, Ordaz B, Peña-Ortega F, Martínez-Torres A, Clapp C, and Thebault S, Prolactin protects retinal pigment epithelium by inhibiting SIRT2-dependent cell death, EBioMedicine, abril de 2016; 7, 35-49

11. Díaz-Lezama N, Wu Z, Adán-Castro E, Arnold E, Vázquez-Membrillo M, Arredondo-Zamarripa D, Ledesma-Colunga MG, Moreno-Carranza B, Martinez de la Escalera G, Colosi P, Clapp C. , Diabetes enhances the efficacy of AAV2 vectors in the retina: therapeutic effect of AAV2 encoding vasoinhibin and soluble VEGF receptor 1, Laboratory Investigation, noviembre de 2015, 1-13

12. Arredondo, D., Díaz-Lezama, N., Meléndez, R., Chávez Balderas, J., Adán, N., Ledesma-Colunga, M.G., Arnold, E., Clapp, C., Thebault, S. , Vasoinhibins regulate the inner and outer blood-retinal barrier and limit retinal oxidative stress, Frontiers in Cellular Neuroscience, octubre de 2014

13. Arnold, E., Thebault, S., Baeza-Cruz, G., Quintanar-Stephano, A., Condés-Lara, M., Rojas-Piloni, G., Binart, N., Martínez de la Escalera, G., Clapp, C., The hormone prolactin is a novel endogenous trophic factor able to regulate reactive glia and to limit retinal degeneration. , Journal Of Neuroscience, enero de 2014; 34(5), 1868-1878

14. Ramírez, M., Wu, Z., Moreno-Carranza, B., Jeziorski, M.C., Arnold, E., Díaz-Lezama, N., Martínez de la Escalera, G., Colosi, P., Clapp, C. , Vasoinhibin gene transfer by Adeno-Associated Virus type 2 protects against VEGF- and diabetes-induced retinal vasopermeability. , Investigative Ophthalmology & Visual Science, noviembre de 2011; 52(11), 8944-8950

15. Arnold E, Rivera JC, Thebault S, Moreno-Páramo D, Quiroz-Mercado H, Quintanar-Stéphano A, Binart N, Martínez de la Escalera G, Clapp C. , High levels of serum prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins. , Diabetes, diciembre de 2010; 59(12), 3192-3197

16. Cruz-Soto ME, Cosío G, Jeziorski MC, Vargas-Barroso V, Aguilar MB, Cárabez A, Berger P, Saftig P, Arnold E, Thebault S, Martínez de la Escalera G, Clapp C, Cathepsin D is the primary protease for the generation of adenohypophyseal vasoinhibins: cleavage occurs within the prolactin secretory granules, Endocrinology, diciembre de 2009; 150(12), 5446-54

17. Melo, A.I., Pérez-Ledezma, M., Clapp, C., Rivera, J.C., Fleming, A.S., Arnold, E. , Effects of prolactin deficiency during the early postnatal period on the development of maternal behavior in female rats: Mother’s milk makes the difference. , Hormones And Behavior, enero de 2009; 59(1), 281-291

18. Clapp C, Thebault S, Arnold E, García C, Rivera JC, Martínez de la Escalera G., Vasoinhibins: Novel inhibitors of ocular angiogenesis, American Journal Of Physiology, Endocrinology And Metabolism, octubre de 2008; 295(4), 772-778

19. García, C., Aranda, J., Arnold, E., Thebault, S., Macotela, J., López-Casillas, F., Mendoza, V., Quiroz-Mercado, H., Lin, S.H., Martínez de la Escalera, G., Clapp, C., Vasoinhibins prevent increased retinal vasopermeability associated with diabetic retinopathy via protein phosphatase 2A-dependent eNOS inactivation, Journal Of Clinical Investigation, junio de 2008; 118(6), 2291-2300

20. Moreno-Páramo, D., Rivera, J.C., Aranda, J., Salazar, N., Arnold, E., Quiróz-Mercado, H., Martínez de la Escalera, G., Clapp, C., RETINOPATIA DIABETICA Y VASOINHIBINAS., Revista de Investigacion Clinica, enero de 2007; 19(0), 290-297